期刊文献+

血清类黏蛋白的功能和临床意义 被引量:2

Function and clinical role of serum orosomucoid
下载PDF
导出
摘要 类黏蛋白(ORM)属于急性时相反应蛋白,机体许多组织和细胞均能合成,但主要的合成器官是肝脏。ORM能够调节参与天然免疫和获得性免疫的多种细胞,平衡机体的能量代谢,并具有抗疲劳作用。许多组织损伤均可诱导细胞及血中的ORM升高。在感染和创伤的过程中,血中ORM水平在炎症的多个阶段均持续升高。因此,监测血中ORM水平能够与C反应蛋白(CRP)互补,反映炎症性疾病的持续、进展和消退情况,从而为精准治疗提供新的线索。文章从ORM的结构特征、生物功能以及检测ORM的临床意义等方面对ORM进行综合性的阐述。 Orosomucoid(ORM)is an acute phase reactive protein synthesized by many tissues and cells,but the liver is the main organ that synthesizes ORM.ORM can adjust various cells participating in innate and acquired immunity,balance energy metabolism,and fight fatigue.The levels of ORM in cells and blood have been shown to increase dramatically resulting from various tissue injuries.In the process of infection or trauma,blood ORM levels are continuously elevated in the multiple phases of inflammation.Therefore,monitoring the level of ORM in blood can be complemented with the current clinical index of emergency response C-reactive protein(CRP).ORM can reflect the persistent,progress and fade status of inflammatory diseases and provide new clues to precise treatment.This review makes a comprehensive exposition of ORM from the aspects of structure,biological function and clinical significance of determining ORM.
作者 王志学 侯晓丹 金新源 宋明明 刘霞 杨义力 WANG Zhixue;HOU Xiaodan;JIN Xinyuan;SONG Mingming;LIU Xia;YANG Yili(Department of Burn and Plastic Surgery,North Campus,Suzhou Municipal Hospital,Suzhou 215008,Jiangsu,China;Center of System Medicine,Chinese Academy of Medical Sciences,Suzhou Institute of System Medicine,Suzhou 215123,Jiangsu,China;Department of Pharmacology,College of Pharmacy,the Second Military Medical University,Shanghai 200433,China)
出处 《检验医学》 CAS 2018年第10期943-948,共6页 Laboratory Medicine
基金 中国医学科学院创新工程重大项目(2016-I2M-1-005) 苏州市临床医学中心建设项目(Szzxj201506)
关键词 类黏蛋白 C反应蛋白 天然免疫 获得性免疫 Orosomucoid C-reactive protein Innate immunity Acquired immunity
  • 相关文献

参考文献1

二级参考文献22

  • 1Maria Papp,Gary L Norman,Istvan Altorjay,Peter Laszlo Lakatos.Utility of serological markers in inflammatory bowel diseases: Gadget or magic?[J].World Journal of Gastroenterology,2007,13(14):2028-2036. 被引量:24
  • 2Ingrid Ordás,Lars Eckmann,Mark Talamini,Daniel C Baumgart,William J Sandborn.Ulcerative colitis[J]. The Lancet . 2012 (9853)
  • 3Bhavya Voleti,David J. Hammond,Avinash Thirumalai,Alok Agrawal.Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter[J]. Molecular Immunology . 2012 (3-4)
  • 4Heba N. Iskandar,Matthew A. Ciorba.Biomarkers in inflammatory bowel disease: current practices and recent advances[J]. Translational Research . 2012 (4)
  • 5Nitin K. Gupta,Ameet I. Thaker,Navya Kanuri,Terrence E. Riehl,Christopher W. Rowley,William F. Stenson,Matthew A. Ciorba.Serum analysis of tryptophan catabolism pathway: Correlation with Crohn’s disease activity[J]. Inflamm Bowel Dis . 2011 (7)
  • 6Shih‐Kuang S.Hong,Brad E.Maltz,Lori A.Coburn,James C.Slaughter,RupeshChaturvedi,David A.Schwartz,Keith T.Wilson.Increased serum levels of L‐arginine in ulcerative colitis and correlation with disease severity[J]. Inflamm Bowel Dis . 2009 (1)
  • 7J.L. Mendoza,M.T. Abreu.Biological markers in inflammatory bowel disease: Practical consideration for clinicians[J]. Gastroenterologie Clinique et Biologique . 2009
  • 8Krithika Balasubramanian,Sandeep Kumar,Rajeev R. Singh,Uma Sharma,Vineet Ahuja,Govind K. Makharia,Naranamangalam R. Jagannathan.Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study[J]. Magnetic Resonance Imaging . 2009 (1)
  • 9Gert Van Assche,Séverine Vermeire,Paul Rutgeerts.Infliximab therapy for patients with inflammatory bowel disease: 10<ce:hsp sp="0.25"/>years on[J]. European Journal of Pharmacology . 2009
  • 10Chad K. Porter,David R. Tribble,Pablo A. Aliaga,Heather A. Halvorson,Mark S. Riddle.Infectious Gastroenteritis and Risk of Developing Inflammatory Bowel Disease[J]. Gastroenterology . 2008 (3)

共引文献13

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部